RENBP and type 2 diabetes mellitus: AGE-RAGE signaling pathway in diabetic complications: The activation of receptor for AGE (RAGE) is a noticeable pathological consequence on T2DM, and thus the design of antagonist for the AGE(RAGE) receptor might be a therapeutic strategy against T2DM [51].